Fosun International LTD Macrogenics Inc Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $1.64 Million - $2.3 Million	-131,573 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$14.51 - $19.71 $783,540 - $1.06 Million	54,000 Added 69.61%	131,573 $2.19 Million
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $123,443 - $284,441	11,111 Added 16.72%	77,573 $1.36 Million
Q4 2018 Jan 31, 2019	BUY	$11.75 - $21.42 $258,500 - $471,240	22,000 Added 49.48%	66,462 $837,000
Q3 2018 Nov 09, 2018	BUY	$19.26 - $23.46 $856,338 - $1.04 Million	44,462 New	44,462 $951,000

131

56M

28.3K

197K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $146M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.